Aarti Drugs has informed that the Finance & Investment Committee at its Meeting held on Saturday, March 7, 2026, approved the investment in equity shares of Pinnacle Life Science, wholly owned subsidiary (WOS) of the Company, upto an aggregate value of INR 10,00,00,000, by way of subscription to the Rights Issue. The details as required under SEBI Listing Regulations read with SEBI Mater Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1792.20 |
| Dr. Reddys Lab | 1271.95 |
| Cipla | 1390.50 |
| Zydus Lifesciences | 1092.05 |
| Lupin | 2279.85 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: